What is Multiplex Assays?
Multiplex assays enable fast and efficient profiling of multiple proteins in a single well using the multianalyte profiling technology. Numerous antibody-based assay platforms have been developed as alternatives to ELISA for the simultaneous measurement of multiple proteins in a single sample. The most common and well-established format for such multiplex assays makes use of flow-based technology and ligand e.g., antibody coated beads. Most importantly, are able to achieve a more comprehensive study of protein signaling in precious samples when multiplexing. For recognition of the immunoassay sandwich compound, the multiplex assays tools use either light-emitting diodes (LEDs) for excitation of each fluorescent bead combined with a CCD camera for bead and analyse detection, or a flow-based detection system using a red and green laser.
The market study is broken down by Type (Nucleic Acid-Based, Protein-Based and Cell-Based), by Application (Companion Diagnostics, Research & Development [Drug Development and Biomarker Discovery & Validation] and Clinical Diagnostics) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Multiplex Assays market throughout the predicted period.
Luminex Corporation (United States), Thermo Fisher Scientific (United States), Illumina (United States), Bio-Rad Laboratories (United States), Qiagen (Germany), Abcam (United Kingdom), Becton Dickinson and Company (United States), Merck (United States), Agilent Technologies (United States), Meso Scale Diagnostics (United States), Randox Laboratories (United Kingdom), Quanterix (United States) and Bio-Techne (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Seegene Inc (South Korea) and Olink (Sweden).
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Multiplex Assays market by Type, Application and Region.
On the basis of geography, the market of Multiplex Assays has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Multiplex PCR will boost the Multiplex Assays market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Product, the sub-segment i.e. Reagents & Consumables will boost the Multiplex Assays market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-Use, the sub-segment i.e. Hospitals will boost the Multiplex Assays market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Trend
- Increasing Incidence of Cancer and Increasing Adoption of Targeted Therapy
Market Drivers
- Rising Use of Multiplex Assays in Companion Diagnostics
- Increasing Adoption due to Advantages over Traditional Assays
Opportunities
- Increasing Validation of Biomarkers in Molecular and Protein Diagnostics
- Improvement in Healthcare Services and Infrastructure in Developing Economies
Restraints
- Stringent Regulations and Standards
Challenges
Key Target Audience
Multiplex Assay Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Healthcare Industry and Others
About Approach
During this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase